Updates are available Erratum dated 2017-11-29
Click to view Erratum: https://doi.org/10.1038/nature24007
-
Authors
Xiang, Yang
Laurent, Benoit
Hsu, Chih-Hung
Nachtergaele, Sigrid
Lu, Zhike
Sheng, Wanqiang
Xu, Chuanyun
Chen, Hao
Ouyang, Jian
Wang, Siqing
Ling, Dominic
Hsu, Pang-Hung
Zou, Lee
Jambhekar, Ashwini
He, Chuan
Shi, Yang
- License Information
-
More Information
Article History
Received: 12 January 2016
Accepted: 27 January 2017
First Online: 15 March 2017
Change Date: 30 November 2017
Change Type: Correction
Change Details: Please see accompanying Corrigendum (). In Extended Data Fig. 4d of this Letter, images in the bottom row, performed with the PARP inhibitor Olaparib, were inadvertently duplicated in panel e (bottom row, under the ‘PARP inhibitor’ heading). The corrected Extended Data Fig. 4e is shown as Supplementary Information to the Corrigendum. In addition, in the ‘Oligonucleotides’ section of the Methods, the two oligonucleotides used for METTL14 should have been listed as: “sh 1, AGCATTGGTGCCGTGTTAAAT ; or sh 2, GCTGACAGATTTGAAGAATAT.” These errors have not been corrected online.
Competing interests
: Y.S. is a cofounder of Constellation Pharmaceuticals and a member of its scientific advisory board, and a consultant for Active Motif, Inc.
